Literature DB >> 3011905

Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression.

J C Reed, A H Abidi, J D Alpers, R G Hoover, R J Robb, P C Nowell.   

Abstract

Here we demonstrate that CsA and DEX, at concentrations that markedly inhibited PHA-induced proliferation and IL 2 mRNA accumulation, partially diminished the expression of receptors for IL 2 on PBMC. This inhibition of IL 2 receptor expression occurred at a pretranslational level and involved a reduction in both high affinity and low affinity forms of the receptor. Although both CsA and DEX inhibited IL 2 receptor expression by about 50%, only CsA blocked the PHA-mediated induction of IL 2 responsivity in PBMC cultures. These data provide evidence that 1) CsA and DEX suppress the proliferation of T lymphocytes through distinct (though perhaps overlapping) mechanisms, 2) CsA (but not DEX) blocks the PHA-mediated induction of signals necessary for T cells to become capable of proliferating in response to IL 2, and 3) T cells regulate the expression of their genes for IL 2 and IL 2 receptors, at least in part, through independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011905

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

Review 1.  Pharmacodynamic monitoring of cyclosporin.

Authors:  W M Awni
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

2.  Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis.

Authors:  M Y Choy; J A Walker-Smith; C B Williams; T T MacDonald
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

3.  A novel mechanism of glucocorticoid-induced immune suppression: the inhibiton of T cell-mediated terminal maturation of a murine dendritic cell line.

Authors:  T Kitajima; K Ariizumi; P R Bergstresser; A Takashima
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

4.  Mechanisms of recrudescence of Mycobacterium bovis BCG infection in mice.

Authors:  J H Cox; B C Knight; J Ivanyi
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

5.  Apoptosis in human thymocytes after treatment with glucocorticoids.

Authors:  M A Nieto; A González; F Gambón; F Díaz-Espada; A López-Rivas
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

Review 6.  The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Authors:  S M Tsunoda; F T Aweeka
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

Review 7.  Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology.

Authors:  Firdaus S Dhabhar
Journal:  Neuroimmunomodulation       Date:  2009-06-29       Impact factor: 2.492

8.  Growth factor mRNA expression in normal colorectal mucosa and in uninvolved mucosa from ulcerative colitis patients.

Authors:  A Chowdhury; R Fukuda; S Fukumoto
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

9.  A role for the intermediate affinity IL-2R in the protection against glucocorticoid-induced apoptosis.

Authors:  A Rebollo; C Pitton; A García; J Gómez; A Silva
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

10.  Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation by dexamethasone, isoproterenol, or prostaglandin E2 either alone or in combination.

Authors:  L Elliott; W Brooks; T Roszman
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.